New Shares are always dilutive on a percentage ownership basis to existing shares,however the new paid in capital, may increase the value of the pre-issue shares, to a level equal to or greater than the pre-issuance, but many times less if the paid in capital is used for settlement of debt or to cover operation expenses.
Authorized but not issued.
Hopefully what they have up their sleeve is for acquisition, and not debt related dilution.,
From a March 5 2014 Press release.
In addition, Paul V. Maier, Chief Financial Officer (CFO) since 2009, will retire effective as of the Annual Meeting. Mr. Maier will serve as a consultant to the Company following his retirement. Carolyn D. Beaver, current Vice President and Chief Accounting Officer, will assume the role of CFO, effective as of the Annual Meeting and immediately upon Mr. Maier's retirement as CFO.
"Paul joined us in October 2009 at a very challenging time in the company's history," said Dr. Hixson. "Sequenom remains ever grateful to him for his major contribution to restoring the company's credibility and balance sheet; contributions that have allowed us to emerge as the leader in the noninvasive prenatal genetic testing field. It has been a great pleasure to work with him, and we wish him many enjoyable years of well-earned retirement."
Ah, young grasshopper, ;ye have yet to find the keys to the secret of the Bots..
One day, all shall be revealed to you.